BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/23/2026 6:25:02 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-12-23 08:14 |
|
Peer-Review Started |
|
2025-12-23 08:15 |
|
First Decision by Editorial Office Director |
|
2026-01-20 09:28 |
|
Return for Revision |
|
2026-01-20 09:28 |
|
Revised |
|
2026-01-27 13:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-28 02:32 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-28 06:44 |
|
Articles in Press |
|
2026-02-28 06:44 |
|
Edit the Manuscript by Language Editor |
|
2026-03-06 20:03 |
|
Typeset the Manuscript |
|
2026-07-20 06:28 |
|
Publish the Manuscript Online |
|
2026-07-23 06:25 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Microbial metabolites and immune regulation in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zi-Ke Chen, Min Shi, Yuan-Bin Wu, Jia-Wei Zhao and Yu-Gang Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yu-Gang Wang, MD, PhD, Department of Gastroenterology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111 Xianxia Road, Shanghai 200336, China. wang_yugang@sina.com |
| Key Words |
Gut-liver axis; Metabolic dysfunction-associated steatotic liver disease; Inflammatory bowel disease; Gut microbiota; Th17-regulatory T cell balance |
| Core Tip |
This letter expands upon the seminal review by Sokal-Dembowska et al. It emphasizes the need to explore the functional consequences of microbial metabolite shifts and the complexity of Th17/regulatory T cell immunology in the gut-liver dialogue of inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease. Specifically, it highlights how specific metabolites and pathogenic Th17 subsets drive hepatic injury and discusses the translational relevance of novel interleukin-23 and sphingosine-1-phosphate receptor modulators. |
| Publish Date |
2026-07-23 06:25 |
| Citation |
Chen ZK, Shi M, Wu YB, Zhao JW, Wang YG. Letter to the Editor: Microbial metabolites and immune regulation in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2026; 32(30): 118010
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i30/118010.htm |
| DOI |
https://doi.org/10.3748/wjg.118010 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
